Search Results - Carlos Bas

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    A microRNA signature of toxic extrasynaptic N-methyl-D-aspartate (NMDA) receptor signaling by Carlos Bas-Orth, Mirja Koch, David Lau, Bettina Buchthal, Hilmar Bading

    Published in Molecular Brain (2020-01-01)
    Get full text
    Article


  2. 2

    Glutamate transporter contribution to retinal ganglion cell vulnerability in a rat model of multiple sclerosis by Isabella Boccuni, Carlos Bas-Orth, Claus Bruehl, Andreas Draguhn, Richard Fairless

    Published in Neurobiology of Disease (2023-10-01)
    Get full text
    Article


  3. 3

    A microscopy-based small molecule screen in primary neurons reveals neuroprotective properties of the FDA-approved anti-viral drug Elvitegravir by Simon F. Merz, C. Peter Bengtson, Clara Tepohl, Anna M. Hagenston, Hilmar Bading, Carlos Bas-Orth

    Published in Molecular Brain (2020-09-01)
    Get full text
    Article


  4. 4

    Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP) by Alejandro Ruiz‐Patiño, Oscar Arrieta, Andrés F. Cardona, Claudio Martín, Luis E. Raez, Zyanya L. Zatarain‐Barrón, Feliciano Barrón, Luisa Ricaurte, María A. Bravo‐Garzón, Luis Mas, Luis Corrales, Leonardo Rojas, Lorena Lupinacci, Florencia Perazzo, Carlos Bas, Omar Carranza, Carmen Puparelli, Manglio Rizzo, Rossana Ruiz, Christian Rolfo, Pilar Archila, July Rodríguez, Carolina Sotelo, Carlos Vargas, Hernán Carranza, Jorge Otero, Luis E. Pino, Carlos Ortíz, Paola Laguado, Rafael Rosell, on behalf of the CLICaP

    Published in Thoracic Cancer (2020-02-01)
    Get full text
    Article


Search Tools: